Nova Eye Medical Ltd (ASX: EYE) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Nova Eye Medical Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $51.49 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 228.82 million
Earnings per share -0.080
Dividend per share N/A
Year To Date Return -8.00%
Earnings Yield N/A
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Nova Eye Medical Ltd (ASX: EYE)
    Latest News

    Share Market News

    Why the Nova Eye (ASX:EYE) share price is surging 7% higher

    The Nova Eye (ASX: EYE) share price is up 7.5% today following the publication of its LEAD trial results. We…

    Read more »

    a woman
    Share Gainers

    Why Cann, Ellex Medical Lasers, Resolute, & Speedcast are racing higher

    The Ellex Medical Lasers Ltd (ASX:ELX) share price and the Speedcast International Ltd (ASX:SDA) share price are two of four…

    Read more »

    a woman
    Share Fallers

    Why Costa, CLINUVEL, Ellex Medical Lasers, & Superloop dropped lower

    The Costa Group Holdings Ltd (ASX:CGC) share price and the Superloop Ltd (ASX:SLC) share price are two of four ending…

    Read more »

    a woman
    Share Fallers

    Why the Ellex Medical Lasers share price crashed lower today

    Here's why the Ellex Medical Lasers Ltd (ASX:ELX) share price crashed lower on Friday...

    Read more »

    a woman
    Share Gainers

    Why Audinate, Ellex Medical Lasers, OceanaGold, & Speedcast stormed higher

    The Audinate Group Ltd (ASX:AD8) share price and the Speedcast International Ltd (ASX:SDA) share price are two of four storming…

    Read more »

    a woman
    Growth Shares

    3 exciting small cap healthcare shares to watch

    Volpara Health Technologies Ltd (ASX:VHT) shares are one of three in the healthcare sector that I think have strong long-term…

    Read more »

    a woman
    Speculative

    3 exciting small cap healthcare shares on my watchlist

    Ellex Medical Lasers Ltd (ASX:ELX) shares are one of three at the small end of the healthcare market worth watching...

    Read more »

    a woman
    Share Fallers

    Why these 4 ASX shares are ending the week in the red

    The Premier Investments Limited (ASX:PMV) share price is one of four ending the week in the red. Here’s why…

    Read more »

    a woman
    Share Market News

    5 things to watch on the ASX on Friday

    The shares of BWX Ltd (ASX:BWX), Ellex Medical Lasers Ltd (ASX: ELX), and Premier Investments Limited (ASX:PMV) will be on…

    Read more »

    a woman
    ⏸️ Investing

    These shares just sank to 52-week lows

    The Caltex Australia Limited (ASX:CTX) share price is one of three sinking to a 52-week low today. Here's why...

    Read more »

    a woman
    ⏸️ Investing

    3 exciting small cap healthcare shares to watch

    Pro Medicus Limited (ASX:PME) shares are one of three in the healthcare sector that I think investors should be watching…

    Read more »

    a woman
    ⏸️ Investing

    Why these 3 small cap shares are climbing higher on Monday

    The Ellex Medical Lasers Ltd (ASX:ELX) share price is one of three in the small cap space climbing higher on…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    21 Jul 2020 $0.1350 100.00% Special Cash 29 Jul 2020

    EYE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Nova Eye Medical Ltd

    Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimallyinvasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.

    EYE Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Jun 2024 $0.22 $0.00 0.00% 381,122 $0.22 $0.23 $0.22
    12 Jun 2024 $0.22 $0.00 0.00% 129,720 $0.22 $0.22 $0.22
    11 Jun 2024 $0.22 $-0.01 -4.55% 700,659 $0.23 $0.23 $0.21
    07 Jun 2024 $0.22 $-0.01 -4.35% 753,504 $0.24 $0.24 $0.22
    06 Jun 2024 $0.23 $0.00 0.00% 238,334 $0.24 $0.24 $0.23
    05 Jun 2024 $0.24 $0.00 0.00% 344,500 $0.25 $0.25 $0.24
    04 Jun 2024 $0.23 $0.00 0.00% 445,638 $0.24 $0.24 $0.23
    03 Jun 2024 $0.24 $-0.01 -4.08% 305,690 $0.25 $0.26 $0.24
    31 May 2024 $0.25 $0.01 4.17% 700,539 $0.24 $0.26 $0.23
    30 May 2024 $0.24 $-0.01 -4.00% 825,898 $0.25 $0.25 $0.24
    29 May 2024 $0.25 $0.00 0.00% 91,154 $0.25 $0.25 $0.25
    28 May 2024 $0.25 $-0.01 -3.92% 607,717 $0.26 $0.26 $0.25
    27 May 2024 $0.26 $-0.02 -7.41% 1,292,869 $0.27 $0.28 $0.25
    24 May 2024 $0.27 $0.01 3.77% 329,528 $0.27 $0.28 $0.26
    23 May 2024 $0.27 $-0.02 -7.14% 580,567 $0.28 $0.28 $0.26
    22 May 2024 $0.28 $0.00 0.00% 808,427 $0.29 $0.29 $0.28
    21 May 2024 $0.29 $-0.01 -3.39% 627,072 $0.30 $0.30 $0.28
    20 May 2024 $0.30 $0.07 30.43% 2,112,045 $0.28 $0.30 $0.27
    17 May 2024 $0.23 $-0.02 -8.00% 871,158 $0.25 $0.25 $0.22
    16 May 2024 $0.25 $-0.01 -3.85% 412,852 $0.25 $0.26 $0.24
    15 May 2024 $0.26 $0.01 3.92% 162,814 $0.26 $0.26 $0.25

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Mar 2024 Victor Previn Issued 1,233,948 $259,129
    Rights issue. As per announcement on 19-03-2024
    15 Mar 2024 Thomas (Tom) Spurling Issued 31,217 $6,555
    Rights issue.
    15 Mar 2024 Thomas (Tom) Spurling Issued 62,700 $13,167
    Rights issue.
    15 Mar 2024 Rahmon Coupe Issued 149,022 $31,294
    Rights issue.
    15 Nov 2023 Thomas (Tom) Spurling Buy 200,000 $25,009
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Victor Previn Executive DirectorExecutive Chairman Jul 2001
    Mr Previn is a professional engineer and one of the original founders of the Company. His career spans more than 35 years in both the ophthalmic laser industry and the wider ophthalmic device sector.Mr Previn held the position of Managing Director from 2003 to 2005. In July of 2005, Mr Previn was elected Chairman of the Board of Directors. He is also a member of Risk Committee.
    Mr Thomas (Tom) Anthony Spurling Managing Director Aug 2020
    Mr Spurling served as the Chief Executive Officer of Ellex Medical Lasers from 2011 to 2019. Tom has close to 30 years of senior executive experience serving in a range of commercial and management roles in Australia and the United States.
    Mr Rahmon Coupe Non-Executive Director May 2013
    Mr Coupe has more than 30 years' experience in the areas of corporate management, intellectual property management, contract negotiation, business development and engineering and has worked across a diverse range of industries, including information technology, life sciences and public broadcasting. Mr Coupe has held various project and engineering management roles for government research-based organisations, including the Defence Science and Technology Organisation (DSTO). He is currently a member Risk Committee.
    Mr Mike Southard Non-Executive Director Dec 2019
    Mr Southard spent 26 years with Alcon Laboratories of Fort Worth, Texas, as Vice President of the Global Surgical business. Prior to this, he was an Executive with Beecham Laboratories (now SmithKline Beecham), and Cooper-Vision, which was acquired by Alcon Laboratories. Mike is currently involved in ophthalmology, dermatology and orthopaedics through his consulting company based in Portland, Oregon, USA. He has experience in both the International and US markets and maintains contacts with many of the world's key opinion leaders in all areas of eye surgery.
    Mr Daniel Webb Non-Executive Director Nov 2022
    Mr Webb is based just outside Toronto, Canada and has a career that has spanned over 40 years in the marketing, sale and distribution of medical devices. After spending 10 years in various positions in ophthalmic device sales, Dan commenced his career with the medical laser company Coherent. In 1990 Dan established Coherent-AMT, now known as Clarion Medical Technologies (Clarion) to import, market, sell and distribute a range of medical devices, focusing on ophthalmic, aesthetic and surgical devices, in Canada. Clarion was sold to a multinational distribution business in 2020
    Mr Simon Ramsey Alexander Gray Company Secretary Jun 2020
    -
    Liam Cook Chief Financial Officer
    -
    Simon Ramsey Alexander Gray Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    National Nominees Limited 35,438,325 18.62%
    J P Morgan Nominees Australia Pty Limited 15,386,778 8.08%
    BOND STREET CUSTODIANS LIMITED 9,359,138 4.92%
    SEDICO PTY LTD <VICTOR PREVIN FAMILY A/C> 7,266,980 3.82%
    Ruminator Pty Ltd 5,062,008 2.66%
    Citicorp Nominees Pty Limited 4,997,894 2.63%
    PINE STREET PTY LTD 4,200,000 2.21%
    CANALA SUPER FUND PTY LTD 3,504,095 1.84%
    Viss Holdings Pty Ltd 1,900,113 1.00%
    INNOVATIVE GLAUCOMA SOLUTIONS LLC 1,736,653 0.91%
    Superhero Securities Limited 1,600,108 0.84%
    SING YING FAMILY PTY LTD 1,459,358 0.77%
    Hsbc Custody Nominees (Australia) Limited 1,393,282 0.73%
    SEDICO PTY LTD <VICTOR PREVIN SUPERFUND A/C> 1,200,000 0.63%
    Dinwoodie Investments Pty Ltd 1,131,851 0.59%
    MR TODD ALFRED CRANE 1,092,279 0.57%
    HSBC Custody Nominees (Australia) Limited (ii) 1,058,331 0.56%
    FAHEY SERVICES PTY LTD 1,050,000 0.55%
    MR DOUGLAS ROBERT BUCHANAN & MRS ROBYN LORRAINE BUCHANAN 1,050,000 0.55%
    MRS GLENIS NITA O'DONNELL 1,030,000 0.54%

    Profile

    since

    Note